Dozens of genes in breast cancer tests have tenuous link to risk
The cost of genetic testing for breast cancer has decreased, but the test itself might not be as effective a predictor of breast cancer risk as thought.
By John Lauerman|May 27, 2015 at 06:35 AM
Thank you for sharing!
Your article was successfully shared with the contacts you provided.
(Bloomberg) — Genetic tests for breast cancer risk often look for DNA flaws that haven’t been reliably linked to the disease, a new report found, casting doubt on diagnostics that examine dozens of genes to calculate a patient’s susceptibility.
Only 11 genes have potential mutations shown to raise the chance of getting breast cancer, according to the article published Wednesday in the New England Journal of Medicine. Some genes included in tests by Illumina Inc. and other companies haven’t been conclusively tied to breast cancer risk, the report said.
Complete your profile to continue reading and get FREE access to BenefitsPRO.com, part of your ALM digital membership.
Your access to unlimited BenefitsPRO.com content isn’t changing. Once you are an ALM digital member, you’ll receive:
Critical BenefitsPRO.com information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events.
Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
It’s no secret that health benefits have struggled to keep up with workforce expectations during the Great Resignation. Remaining competitive means employers must streamline their health benefits, put employees first and deliver on brand values. Download this guide to help your clients gain an edge in 2022 with their health benefits.
Amid mass resignations and record-high job openings, employees are now firmly in the driver’s seat when it comes to where and how they work. So, how are you going to stand out in this highly competitive market? This guide outlines a forward-thinking health benefits strategy that will ensure your company remains competitive in 2022 and beyond.
Millennials and Gen Z value tobacco and nicotine cessation more than ever before, but quit programs must adapt to their evolving needs. New research indicates successful quit programs have three key facets. Download this interactive ebook to learn how to set your company apart with an effective quit services benefit.